Recombinant DNA Technology Market 2030: Innovations Driving Healthcare Forward
The global market for recombinant DNA technology (RDT) was valued at a substantial USD 728.9 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2030. This impressive growth is largely propelled by the increasing adoption of genetic engineering across vital sectors such as healthcare, agriculture, and industrial biotechnology. RDT is proving indispensable in healthcare, enabling the creation of novel vaccines and groundbreaking drugs, and its demand is further amplified by the escalating need for protein therapeutics and monoclonal antibodies. RDT has truly revolutionized biological research, becoming an essential tool for enhancing traits in living organisms. Its widespread applications across diverse disciplines—including medicine, agriculture, and various industries—are key drivers of its continued growth. A primary factor fueling this expansion is the surging demand for effective treatments for a myriad of ailments, w...